Yahoo Web Search

Search results

    • Is This a Setback for Moderna?

      Is This a Setback for Moderna?

      The Motley Fool via AOL· 1 day ago

      Even if Moderna falls short of its product launch goal, it's still likely to become a multiple-product biotech company in the near future. That means...

    • CompoSecure (NASDAQ:CMPO) Price Target Raised to $10.00

      ETF DAILY NEWS· 5 days ago

      CompoSecure (NASDAQ:CMPO – Free Report) had its price objective lifted by Benchmark from $8.00 to $10.00 in a research note released on Tuesday morning, Benzinga reports. The brokerage currently ...